The present invention relates to fused pyrrolidino-cyclopropane derivativesaccording to Formulae (I) to (II), as selectiveinhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1(11-.beta.-HSD-1 ) and the use of such compounds forthe treatment and/or prevention of metabolic syndrome, diabetes, insulinresistance, obesity, lipid disorders, glaucoma,osteoporosis/ cognitive disorders, anxiety, depression, immune disorders,hypertension and other diseases and conditions.